(MedPage Today) — The FDA approved a label change for the birth control shot depot medroxyprogesterone acetate (Depo-Provera), which now warns about the risk of meningioma, according to a letter posted on the agency website on Friday.
The new…
Source link : https://www.medpagetoday.com/neurology/braincancer/119061
Author :
Publish date : 2025-12-17 17:10:00
Copyright for syndicated content belongs to the linked Source.
